{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "Global pandemic", "Investigational drugs", "SARS-CoV-2", "Vaccine development", "Virus mechanism"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32991900", "DateCompleted": {"Year": "2020", "Month": "12", "Day": "17"}, "DateRevised": {"Year": "2023", "Month": "03", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "09", "Day": "28"}], "Language": ["eng"], "ELocationID": ["10.1016/j.ijbiomac.2020.09.204", "S0141-8130(20)34564-5"], "Journal": {"ISSN": "1879-0003", "JournalIssue": {"Volume": "165", "Issue": "Pt A", "PubDate": {"Year": "2020", "Month": "Dec", "Day": "15"}}, "Title": "International journal of biological macromolecules", "ISOAbbreviation": "Int J Biol Macromol"}, "ArticleTitle": "Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials.", "Pagination": {"StartPage": "18", "EndPage": "43", "MedlinePgn": "18-43"}, "Abstract": {"AbstractText": ["The emergence of the global pandemic caused by the novel SARS-CoV-2 virus has motivated scientists to find a definitive treatment or a vaccine against it in the shortest possible time. Current efforts towards this goal remain fruitless without a full understanding of the behavior of the virus and its adaptor proteins. This review provides an overview of the biological properties, functional mechanisms, and molecular components of SARS-CoV-2, along with investigational therapeutic and preventive approaches for this virus. Since the proteolytic cleavage of the S protein is critical for virus penetration into cells, a set of drugs, such as chloroquine, hydroxychloroquine, camostat mesylate have been tested in clinical trials to suppress this event. In addition to angiotensin-converting enzyme 2, the role of CD147 in the viral entrance has also been proposed. Mepolizumab has shown to be effective in blocking the virus's cellular entrance. Antiviral drugs, such as remdesivir, ritonavir, oseltamivir, darunavir, lopinavir, zanamivir, peramivir, and oseltamivir, have also been tested as treatments for COVID-19. Regarding preventive vaccines, the whole virus, vectors, nucleic acids, and structural subunits have been suggested for vaccine development. Mesenchymal stem cells and natural killer cells could also be used against SARS-CoV-2. All the above-mentioned strategies, as well as the role of nanomedicine for the diagnosis and treatment of SARS-CoV-2 infection, have been discussed in this review."], "CopyrightInformation": "Copyright \u00a9 2020 Elsevier B.V. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Advanced Sciences and Technologies in Medicine, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran; Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Oroojalian", "ForeName": "Fatemeh", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pediatrics, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran; Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Haghbin", "ForeName": "Ali", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Baradaran", "ForeName": "Behzad", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Hemmat", "ForeName": "Nima", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki FI-00014, Finland; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran."}], "LastName": "Shahbazi", "ForeName": "Mohammad-Ali", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Baghi", "ForeName": "Hossein Bannazadeh", "Initials": "HB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: mokhtarzadehah@tbzmed.ac.ir."}], "LastName": "Mokhtarzadeh", "ForeName": "Ahad", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Dermatology, Harvard Medical School, Boston, MA 02115, USA; Laser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein 2028, South Africa. Electronic address: hamblin@helix.mgh.harvard.edu."}], "LastName": "Hamblin", "ForeName": "Michael R", "Initials": "MR"}], "GrantList": [{"GrantID": "R01 AI050875", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "R21 AI121700", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Int J Biol Macromol", "NlmUniqueID": "7909578", "ISSNLinking": "0141-8130"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Viral Vaccines"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["immunology", "therapy"], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Clinical Trials as Topic"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects", "immunology", "physiology"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["immunology"], "DescriptorName": "Viral Vaccines"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "Declaration of competing interest MRH declares the following potential conflicts of interest. Scientific Advisory Boards: Transdermal Cap Inc., Cleveland, OH; BeWell Global Inc., Wan Chai, Hong Kong; Hologenix Inc. Santa Monica, CA; LumiThera Inc., Poulsbo, WA; Vielight, Toronto, Canada; Bright Photomedicine, Sao Paulo, Brazil; Quantum Dynamics LLC, Cambridge, MA; Global Photon Inc., Bee Cave, TX; Medical Coherence, Boston MA; NeuroThera, Newark DE; JOOVV Inc., Minneapolis-St. Paul MN; AIRx Medical, Pleasanton CA; FIR Industries, Inc. Ramsey, NJ; UVLRx Therapeutics, Oldsmar, FL; Ultralux UV Inc., Lansing MI; Illumiheal & Petthera, Shoreline, WA; MB Lasertherapy, Houston, TX; ARRC LED, San Clemente, CA; Varuna Biomedical Corp. Incline Village, NV; Niraxx Light Therapeutics, Inc., Boston, MA. Consulting; Lexington Int, Boca Raton, FL; USHIO Corp, Japan; Merck KGaA, Darmstadt, Germany; Philips Electronics Nederland B.V. Eindhoven, Netherlands; Johnson & Johnson Inc., Philadelphia, PA; Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany. Stockholdings: Global Photon Inc., Bee Cave, TX; Mitonix, Newark, DE."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Kahn J.S., McIntosh K. History and recent advances in coronavirus discovery. Pediatr. Infect. Dis. J. 2005;24(11):S223\u2013S227.", "ArticleIdList": ["16378050"]}, {"Citation": "Geller C., Varbanov M., Duval R.E. Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies. Viruses. 2012;4(11):3044\u20133068.", "ArticleIdList": ["PMC3509683", "23202515"]}, {"Citation": "van der Hoek L. Human coronaviruses: what do they cause? Antivir. Ther. 2007;12(4 Pt B):651.", "ArticleIdList": ["17944272"]}, {"Citation": "de Groot R.J., Baker S.C., Baric R.S., Brown C.S., Drosten C., Enjuanes L., Fouchier R.A., Galiano M., Gorbalenya A.E., Memish Z.A. Commentary: Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J. Virol. 2013;87(14):7790\u20137792.", "ArticleIdList": ["PMC3700179", "23678167"]}, {"Citation": "C.S.G. of the International The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 2020:1.", "ArticleIdList": ["PMC7095448", "32123347"]}, {"Citation": "W.H. Organization . 2020, April 5. Coronavirus Disease 2019 (COVID-19): Situation Report-76."}, {"Citation": "Sola I., Almazan F., Zuniga S., Enjuanes L. Continuous and discontinuous RNA synthesis in coronaviruses. Annual review of virology. 2015;2:265\u2013288.", "ArticleIdList": ["PMC6025776", "26958916"]}, {"Citation": "Li F. Receptor recognition and cross-species infections of SARS coronavirus. Antivir. Res. 2013;100(1):246\u2013254.", "ArticleIdList": ["PMC3840050", "23994189"]}, {"Citation": "C.S.M.E. Consortium Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science. 2004;303(5664):1666\u20131669.", "ArticleIdList": ["14752165"]}, {"Citation": "Zheng J. SARS-CoV-2: an emerging coronavirus that causes a global threat. Int. J. Biol. Sci. 2020;16(10):1678.", "ArticleIdList": ["PMC7098030", "32226285"]}, {"Citation": "Li G., Fan Y., Lai Y., Han T., Li Z., Zhou P., Pan P., Wang W., Hu D., Liu X. Coronavirus infections and immune responses. J. Med. Virol. 2020;92(4):424\u2013432.", "ArticleIdList": ["PMC7166547", "31981224"]}, {"Citation": "Dandekar A.A., Perlman S. Immunopathogenesis of coronavirus infections: implications for SARS. Nat. Rev. Immunol. 2005;5(12):917\u2013927.", "ArticleIdList": ["PMC7097326", "16322745"]}, {"Citation": "B.G. National Research Project for SARS The involvement of natural killer cells in the pathogenesis of severe acute respiratory syndrome. Am. J. Clin. Pathol. 2004;121(4):507\u2013511.", "ArticleIdList": ["PMC7110090", "15080302"]}, {"Citation": "Glass W.G., Subbarao K., Murphy B., Murphy P.M. Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J. Immunol. 2004;173(6):4030\u20134039.", "ArticleIdList": ["15356152"]}, {"Citation": "Chen J.-H., Chang Y.-W., Yao C.-W., Chiueh T.-S., Huang S.-C., Chien K.-Y., Chen A., Chang F.-Y., Wong C.-H., Chen Y.-J. Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional gel electrophoresis and mass spectrometry. Proc. Natl. Acad. Sci. 2004;101(49):17039\u201317044.", "ArticleIdList": ["PMC535397", "15572443"]}, {"Citation": "Spiegel M., Pichlmair A., Mart\u00ednez-Sobrido L., Cros J., Garc\u00eda-Sastre A., Haller O., Weber F. Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J. Virol. 2005;79(4):2079\u20132086.", "ArticleIdList": ["PMC546554", "15681410"]}, {"Citation": "Yilla M., Harcourt B.H., Hickman C.J., McGrew M., Tamin A., Goldsmith C.S., Bellini W.J., Anderson L.J. SARS-coronavirus replication in human peripheral monocytes/macrophages. Virus Res. 2005;107(1):93\u2013101.", "ArticleIdList": ["PMC7114182", "15567038"]}, {"Citation": "Law H.K., Cheung C.Y., Ng H.Y., Sia S.F., Chan Y.O., Luk W., Nicholls J.M., Peiris J.M., Lau Y.L. Chemokine up-regulation in sars-coronavirus\u2013infected, monocyte-derived human dendritic cells. Blood. 2005;106(7):2366\u20132374.", "ArticleIdList": ["PMC1895271", "15860669"]}, {"Citation": "Wang Y.-D., Sin W.-Y.F., Xu G.-B., Yang H.-H., Wong T.-y., Pang X.-W., He X.-Y., Zhang H.-G., Ng J.N.L., Cheng C.-S.S. T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS. J. Virol. 2004;78(11):5612\u20135618.", "ArticleIdList": ["PMC415819", "15140958"]}, {"Citation": "Wong R.S., Wu A., To K., Lee N., Lam C.W., Wong C., Chan P.K., Ng M.H., Yu L., Hui D.S. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. Bmj. 2003;326(7403):1358\u20131362.", "ArticleIdList": ["PMC162124", "12816821"]}, {"Citation": "Hsueh P.-R., Huang L.-M., Chen P.-J., Kao C.-L., Yang P.-C. Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus. Clin. Microbiol. Infect. 2004;10(12):1062\u20131066.", "ArticleIdList": ["PMC7129952", "15606632"]}, {"Citation": "Buchholz U.J., Bukreyev A., Yang L., Lamirande E.W., Murphy B.R., Subbarao K., Collins P.L. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proc. Natl. Acad. Sci. 2004;101(26):9804\u20139809.", "ArticleIdList": ["PMC470755", "15210961"]}, {"Citation": "Du L., He Y., Zhou Y., Liu S., Zheng B.J., Jiang S. The spike protein of SARS-CoV\u2014a target for vaccine and therapeutic development. Nat. Rev. Microbiol. 2009;7(3):226\u2013236.", "ArticleIdList": ["PMC2750777", "19198616"]}, {"Citation": "Li X., Geng M., Peng Y., Meng L., Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J. Pharm. Anal. 2020;10:102\u2013108.", "ArticleIdList": ["PMC7104082", "32282863"]}, {"Citation": "Laureti M., Narayanan D., Rodriguez-Andres J., Fazakerley J.K., Kedzierski L. Flavivirus receptors: diversity, identity, and cell entry. Front. Immunol. 2018;9:2180.", "ArticleIdList": ["PMC6168832", "30319635"]}, {"Citation": "Mazzon M., Marsh M. Targeting viral entry as a strategy for broad-spectrum antivirals. F1000Res. 2019:8.", "ArticleIdList": ["PMC6743247", "31559009"]}, {"Citation": "Millet J.K., Whittaker G.R. Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. Proc. Natl. Acad. Sci. U. S. A. 2014;111(42):15214\u201315219.", "ArticleIdList": ["PMC4210292", "25288733"]}, {"Citation": "White J.M., Delos S.E., Brecher M., Schornberg K. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit. Rev. Biochem. Mol. Biol. 2008;43(3):189\u2013219.", "ArticleIdList": ["PMC2649671", "18568847"]}, {"Citation": "Thorley J.A., McKeating J.A., Rappoport J.Z. Mechanisms of viral entry: sneaking in the front door. Protoplasma. 2010;244(1\u20134):15\u201324.", "ArticleIdList": ["PMC3038234", "20446005"]}, {"Citation": "Boulant S., Stanifer M., Lozach P.Y. Dynamics of virus-receptor interactions in virus binding, signaling, and endocytosis. Viruses. 2015;7(6):2794\u20132815.", "ArticleIdList": ["PMC4488714", "26043381"]}, {"Citation": "Tikellis C., Bernardi S., Burns W.C. Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease. Curr. Opin. Nephrol. Hypertens. 2011;20(1):62\u201368.", "ArticleIdList": ["21099686"]}, {"Citation": "Clarke N.E., Turner A.J. Angiotensin-converting enzyme 2: the first decade. Int. J. Hypertens. 2012;2012:307315.", "ArticleIdList": ["PMC3216391", "22121476"]}, {"Citation": "Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W., Si H.R., Zhu Y., Li B., Huang C.L., Chen H.D., Chen J., Luo Y., Guo H., Jiang R.D., Liu M.Q., Chen Y., Shen X.R., Wang X., Zheng X.S., Zhao K., Chen Q.J., Deng F., Liu L.L., Yan B., Zhan F.X., Wang Y.Y., Xiao G.F., Shi Z.L. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270\u2013273.", "ArticleIdList": ["PMC7095418", "32015507"]}, {"Citation": "Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q. Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2. Science. 2020;367:1444\u20131448.", "ArticleIdList": ["PMC7164635", "32132184"]}, {"Citation": "Cao Y., Li L., Feng Z., Wan S., Huang P., Sun X., Wen F., Huang X., Ning G., Wang W. Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell Discov. 2020;6:11.", "ArticleIdList": ["PMC7040011", "32133153"]}, {"Citation": "Wang K., Chen W., Zhou Y.-S., Lian J.-Q., Zhang Z., Du P., Gong L., Zhang Y., Cui H., Geng J.-J., Wang B., Sun X.-X., Wang C.-F., Yang X., Lin P., Deng Y.-Q., Wei D., Yang X.-M., Zhu Y.-M. 2020. SARS-CoV-2 Invades Host Cells Via a Novel Route: CD147-spike Protein.", "ArticleIdList": ["PMC7714896", "33277466"]}, {"Citation": "Guindolet D., Gabison E. Role of CD147 (EMMPRIN/basigin) in tissue remodeling. Anat. Rec. 2020;367:1444\u20131448.", "ArticleIdList": ["30768865"]}, {"Citation": "Dolin H.H., Papadimos T.J., Chen X., Pan Z.K. Characterization of pathogenic sepsis etiologies and patient profiles: a novel approach to triage and treatment. Microbiol Insights. 2019;12 (1178636118825081)", "ArticleIdList": ["PMC6350122", "30728724"]}, {"Citation": "Chen W. Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection. J. Med. Microbiol. 2004;53:435\u2013438.", "ArticleIdList": ["15096554"]}, {"Citation": "Patel V.B., Zhong J.C., Grant M.B., Oudit G.Y. Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure. Circ. Res. 2016;118(8):1313\u20131326.", "ArticleIdList": ["PMC4939482", "27081112"]}, {"Citation": "Grass G.D., Toole B.P. How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity. Biosci. Rep. 2015;36(1):e00283.", "ArticleIdList": ["PMC4718507", "26604323"]}, {"Citation": "Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol. 2016;3(1):237\u2013261.", "ArticleIdList": ["PMC5457962", "27578435"]}, {"Citation": "Xu X., Chen P., Wang J., Feng J., Zhou H., Li X., Zhong W., Hao P. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci. China Life Sci. 2020;63(3):457\u2013460.", "ArticleIdList": ["PMC7089049", "32009228"]}, {"Citation": "Li F., Li W., Farzan M., Harrison S.C. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science. 2005;309(5742):1864\u20131868.", "ArticleIdList": ["16166518"]}, {"Citation": "Liu Z., Xiao X., Wei X., Li J., Yang J., Tan H., Zhu J., Zhang Q., Wu J., Liu L. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J. Med. Virol. 2020;92:595\u2013601.", "ArticleIdList": ["PMC7228221", "32100877"]}, {"Citation": "Chen Y., Guo Y., Pan Y., Zhao Z.J. Structure analysis of the receptor binding of 2019-nCoV. Biochem. Biophys. Res. Commun. 2020;525:135\u2013140.", "ArticleIdList": ["PMC7092824", "32081428"]}, {"Citation": "Wrapp D., Wang N., Corbett K.S., Goldsmith J.A., Hsieh C.L., Abiona O., Graham B.S., McLellan J.S. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367:1260\u20131263.", "ArticleIdList": ["PMC7164637", "32075877"]}, {"Citation": "Kirchdoerfer R.N., Wang N., Pallesen J., Wrapp D., Turner H.L., Cottrell C.A., Corbett K.S., Graham B.S., McLellan J.S., Ward A.B. Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis. Sci. Rep. 2018;8(1):15701.", "ArticleIdList": ["PMC6200764", "30356097"]}, {"Citation": "Towler P., Staker B., Prasad S.G., Menon S., Tang J., Parsons T., Ryan D., Fisher M., Williams D., Dales N.A., Patane M.A., Pantoliano M.W. ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J. Biol. Chem. 2004;279(17):17996\u201318007.", "ArticleIdList": ["PMC7980034", "14754895"]}, {"Citation": "Xiao X., Chakraborti S., Dimitrov A.S., Gramatikoff K., Dimitrov D.S. The SARS-CoV S glycoprotein: expression and functional characterization. Biochem. Biophys. Res. Commun. 2003;312(4):1159\u20131164.", "ArticleIdList": ["PMC7111010", "14651994"]}, {"Citation": "Sigrist C.J., Bridge A., Le Mercier P. A potential role for integrins in host cell entry by SARS-CoV-2. Antivir. Res. 2020;177", "ArticleIdList": ["PMC7114098", "32130973"]}, {"Citation": "Wu K., Peng G., Wilken M., Geraghty R.J., Li F. Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus. J. Biol. Chem. 2012;287(12):8904\u20138911.", "ArticleIdList": ["PMC3308800", "22291007"]}, {"Citation": "Wan Y., Shang J., Graham R., Baric R.S., Li F. Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J. Virol. 2020;94", "ArticleIdList": ["PMC7081895", "31996437"]}, {"Citation": "Yamauchi Y., Greber U.F. Principles of virus uncoating: cues and the snooker ball. Traffic. 2016;17(6):569\u2013592.", "ArticleIdList": ["PMC7169695", "26875443"]}, {"Citation": "Belouzard S., Millet J.K., Licitra B.N., Whittaker G.R. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses. 2012;4(6):1011\u20131033.", "ArticleIdList": ["PMC3397359", "22816037"]}, {"Citation": "Shang J., Wan Y., Liu C., Yount B., Gully K., Jian Y., Auerbach A., Peng G., Baric R., Li F. Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry. PLoS Pathog. 2020;16:e1008392.", "ArticleIdList": ["PMC7082060", "32150576"]}, {"Citation": "Heald-Sargent T., Gallagher T. Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competence. Viruses. 2012;4(4):557\u2013580.", "ArticleIdList": ["PMC3347323", "22590686"]}, {"Citation": "Sobhy H. A comparative review of viral entry and attachment during large and giant dsDNA virus infections. Arch. Virol. 2017;162(12):3567\u20133585.", "ArticleIdList": ["PMC5671522", "28866775"]}, {"Citation": "Hantak M.P., Qing E., Earnest J.T., Gallagher T. Tetraspanins: architects of viral entry and exit platforms. J. Virol. 2019;93(6)", "ArticleIdList": ["PMC6401424", "30567993"]}, {"Citation": "Millet J.K., Whittaker G.R. Host cell proteases: critical determinants of coronavirus tropism and pathogenesis. Virus Res. 2015;202:120\u2013134.", "ArticleIdList": ["PMC4465284", "25445340"]}, {"Citation": "Millet J., Whittaker G. Host cell proteases: critical determinants of coronavirus tropism and pathogenesis. Virus Res. 2015;202:120\u2013134.", "ArticleIdList": ["PMC4465284", "25445340"]}, {"Citation": "Hoffmann M., Kleine-Weber H., Schroeder S., Kruger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., Muller M.A., Drosten C., Pohlmann S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2005;102:11876\u201311881.", "ArticleIdList": ["PMC7102627", "32142651"]}, {"Citation": "Glowacka I., Bertram S., Muller M.A., Allen P., Soilleux E., Pfefferle S., Steffen I., Tsegaye T.S., He Y., Gnirss K., Niemeyer D., Schneider H., Drosten C., Pohlmann S. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J. Virol. 2011;85(9):4122\u20134134.", "ArticleIdList": ["PMC3126222", "21325420"]}, {"Citation": "Simmons G., Gosalia D.N., Rennekamp A.J., Reeves J.D., Diamond S.L., Bates P. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci. U. S. A. 2005;102(33):11876\u201311881.", "ArticleIdList": ["PMC1188015", "16081529"]}, {"Citation": "Adedeji A., Severson W., Jonsson C., Singh K., Weiss S., Sarafianos S. Novel inhibitors of SARS-CoV entry acting by three distinct mechanisms. J. Virol. 2013;87", "ArticleIdList": ["PMC3700180", "23678171"]}, {"Citation": "Struck A.-W., Axmann M., Pfefferle S., Drosten C., Meyer B. A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2. Antivir. Res. 2012;94:288\u2013296.", "ArticleIdList": ["PMC7114193", "22265858"]}, {"Citation": "Abraham H.M., White C.M., White W.B. The comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases. Drug Saf. 2015;38(1):33\u201354.", "ArticleIdList": ["PMC4303500", "25416320"]}, {"Citation": "Gurwitz D. Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Dev. Res. 2020;81:537\u2013540.", "ArticleIdList": ["PMC7228359", "32129518"]}, {"Citation": "Kim J.Y. Letter to the editor: case of the index patient who caused tertiary transmission of coronavirus disease 2019 in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 pneumonia monitored by quantitative RT-PCR. J. Korean Med. Sci. 2020;35(7):e88.", "ArticleIdList": ["PMC7036343", "32080992"]}, {"Citation": "Cao B., Wang Y., Wen D., Liu W., Wang J., Fan G., Ruan L., Song B., Cai Y., Wei M., Li X., Xia J., Chen N., Xiang J., Yu T., Bai T., Xie X., Zhang L., Li C., Yuan Y., Chen H., Li H., Huang H., Tu S., Gong F., Liu Y., Wei Y., Dong C., Zhou F., Gu X., Xu J., Liu Z., Zhang Y., Li H., Shang L., Wang K., Li K., Zhou X., Dong X., Qu Z., Lu S., Hu X., Ruan S., Luo S., Wu J., Peng L., Cheng F., Pan L., Zou J., Jia C., Wang J., Liu X., Wang S., Wu X., Ge Q., He J., Zhan H., Qiu F., Guo L., Huang C., Jaki T., Hayden F.G., Horby P.W., Zhang D., Wang C. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N. Engl. J. Med. 2020;382:1787\u20131799.", "ArticleIdList": ["PMC7121492", "32187464"]}, {"Citation": "Bhatnagar T., Murhekar M.V., Soneja M., Gupta N., Giri S., Wig N., Gangakhedkar R. Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: protocol for restricted public health emergency use. Indian J. Med. Res. 2020;151:184\u2013189.", "ArticleIdList": ["PMC7288773", "32362644"]}, {"Citation": "Lim J., Jeon S., Shin H.Y., Kim M.J., Seong Y.M., Lee W.J., Choe K.W., Kang Y.M., Lee B., Park S.J. Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR. J. Korean Med. Sci. 2020;35(6):e79.", "ArticleIdList": ["PMC7025910", "32056407"]}, {"Citation": "Hama R., Bennett C.L. The mechanisms of sudden-onset type adverse reactions to oseltamivir. Acta Neurol. Scand. 2017;135(2):148\u2013160.", "ArticleIdList": ["PMC5201449", "27364959"]}, {"Citation": "Guo Y.R., Cao Q.D., Hong Z.S., Tan Y.Y., Chen S.D., Jin H.J., Tan K.S., Wang D.Y., Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7(1):11.", "ArticleIdList": ["PMC7068984", "32169119"]}, {"Citation": "Lung J., Lin Y.-S., Yang Y.-H., Chou Y.-L., Shu L.-H., Cheng Y.-C., Liu H.T., Wu C.-Y. The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase. J. Med. Virol. 2020;92:693\u2013697.", "ArticleIdList": ["PMC7228302", "32167173"]}, {"Citation": "Li G., De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV) Nat. Rev. Drug Discov. 2020;19(3):149\u2013150.", "ArticleIdList": ["32127666"]}, {"Citation": "De Clercq E. New nucleoside analogues for the treatment of hemorrhagic fever virus infections. Chem. Asian J. 2019;14(22):3962\u20133968.", "ArticleIdList": ["PMC7159701", "31389664"]}, {"Citation": "Chan J.F., Lau S.K., To K.K., Cheng V.C., Woo P.C., Yuen K.Y. Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin. Microbiol. Rev. 2015;28(2):465\u2013522.", "ArticleIdList": ["PMC4402954", "25810418"]}, {"Citation": "Arabi Y.M., Balkhy H.H., Hayden F.G., Bouchama A., Luke T., Baillie J.K., Al-Omari A., Hajeer A.H., Senga M., Denison M.R., Nguyen-Van-Tam J.S., Shindo N., Bermingham A., Chappell J.D., Van Kerkhove M.D., Fowler R.A. Middle East respiratory syndrome. N. Engl. J. Med. 2017;376(6):584\u2013594.", "ArticleIdList": ["PMC5362064", "28177862"]}, {"Citation": "Menachery V.D., Yount B.L., Jr., Sims A.C., Debbink K., Agnihothram S.S., Gralinski L.E., Graham R.L., Scobey T., Plante J.A., Royal S.R., Swanstrom J., Sheahan T.P., Pickles R.J., Corti D., Randell S.H., Lanzavecchia A., Marasco W.A., Baric R.S. SARS-like WIV1-CoV poised for human emergence. Proc. Natl. Acad. Sci. U. S. A. 2016;113(11):3048\u20133053.", "ArticleIdList": ["PMC4801244", "26976607"]}, {"Citation": "Agostini M., Andres E., Sims A., Graham R., Sheahan T., Lu X., Smith E., Case J., Feng J., Jordan R., Ray A., Cihlar T., Siegel D., Mackman R., Clarke M., Baric R., Denison M. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. mBio. 2018;9", "ArticleIdList": ["PMC5844999", "29511076"]}, {"Citation": "Menzel M., Akbarshahi H., Bjermer L., Uller L. Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients. Sci. Rep. 2016;6", "ArticleIdList": ["PMC4923851", "27350308"]}, {"Citation": "Retallack H., Di Lullo E., Arias C., Knopp K.A., Laurie M.T., Sandoval-Espinosa C., Mancia Leon W.R., Krencik R., Ullian E.M., Spatazza J., Pollen A.A., Mandel-Brehm C., Nowakowski T.J., Kriegstein A.R., DeRisi J.L. Zika virus cell tropism in the developing human brain and inhibition by azithromycin. Proc. Natl. Acad. Sci. U. S. A. 2016;113(50):14408\u201314413.", "ArticleIdList": ["PMC5167169", "27911847"]}, {"Citation": "Bosseboeuf E., Aubry M., Nhan T., Pina J., Rolain J., Raoult D., Musso D. Azithromycin inhibits the replication of Zika virus. Journal of Antivirals & Antiretrovirals. 2018;10"}, {"Citation": "Madrid P.B., Panchal R.G., Warren T.K., Shurtleff A.C., Endsley A.N., Green C.E., Kolokoltsov A., Davey R., Manger I.D., Gilfillan L., Bavari S., Tanga M.J. Evaluation of Ebola virus inhibitors for drug repurposing. ACS Infect Dis. 2015;1(7):317\u2013326.", "ArticleIdList": ["27622822"]}, {"Citation": "Bacharier L.B., Guilbert T.W., Mauger D.T., Boehmer S., Beigelman A., Fitzpatrick A.M., Jackson D.J., Baxi S.N., Benson M., Burnham C.D., Cabana M., Castro M., Chmiel J.F., Covar R., Daines M., Gaffin J.M., Gentile D.A., Holguin F., Israel E., Kelly H.W., Lazarus S.C., Lemanske R.F., Jr., Ly N., Meade K., Morgan W., Moy J., Olin T., Peters S.P., Phipatanakul W., Pongracic J.A., Raissy H.H., Ross K., Sheehan W.J., Sorkness C., Szefler S.J., Teague W.G., Thyne S., Martinez F.D. Early administration of azithromycin and prevention of severe lower respiratory tract illnesses in preschool children with a history of such illnesses: a randomized clinical trial. Jama. 2015;314(19):2034\u20132044.", "ArticleIdList": ["PMC4757487", "26575060"]}, {"Citation": "Gautret P., Lagier J.C., Parola P., Hoang V.T., Meddeb L., Mailhe M., Doudier B., Courjon J., Giordanengo V., Vieira V.E., Dupont H.T., Honore S., Colson P., Chabriere E., La Scola B., Rolain J.M., Brouqui P., Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int. J. Antimicrob. Agents. 2020:105949.", "ArticleIdList": ["PMC7102549", "32205204"]}, {"Citation": "Theoharides T., Conti P. Dexamethasone for COVID-19? Not so fast. J. Biol. Regul. Homeost. Agents. 2020;34(3):10.23812.", "ArticleIdList": ["32551464"]}, {"Citation": "Hassan M.E., Hasan H.M., Sridharan K., Elkday A., ElSeirafi M.M. Dexamethasone in severe COVID-19 infection: a case series. Respiratory Medicine Case Reports. 2020:101205.", "ArticleIdList": ["PMC7452843", "32874905"]}, {"Citation": "Lammers T., Sofias A.M., van der Meel R., Schiffelers R., Storm G., Tacke F., Koschmieder S., Br\u00fcmmendorf T.H., Kiessling F., Metselaar J.M. Dexamethasone nanomedicines for COVID-19. Nat. Nanotechnol. 2020:1\u20133.", "ArticleIdList": ["PMC7116110", "32747742"]}, {"Citation": "Quan L., Zhang Y., Crielaard B.J., Dusad A., Lele S.M., Rijcken C.J., Metselaar J.M., Kostkov\u00e1 H., Etrych T.s., Ulbrich K. Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes. ACS Nano. 2014;8(1):458\u2013466.", "ArticleIdList": ["PMC3947749", "24341611"]}, {"Citation": "Gouglas D., Le T., Henderson K., Kaloudis A., Danielsen T., Hammersland N., Robinson J., Heaton P., R\u00f8ttingen J.-A. Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study. Lancet Glob. Health. 2018;6", "ArticleIdList": ["PMC7164811", "30342925"]}, {"Citation": "El Zowalaty M.E., J\u00e4rhult J.D. From SARS to COVID-19: a previously unknown SARS- related coronavirus (SARS-CoV-2) of pandemic potential infecting humans \u2013 call for a one health approach. One Health. 2020;9", "ArticleIdList": ["PMC7075990", "32195311"]}, {"Citation": "Lu S. Timely development of vaccines against SARS-CoV-2. Emerg Microbes Infect. 2020;9(1):542\u2013544.", "ArticleIdList": ["PMC7144304", "32148172"]}, {"Citation": "Yong C.Y., Ong H.K., Yeap S.K., Ho K.L., Tan W.S. Recent advances in the vaccine development against Middle East respiratory syndrome-coronavirus. Front. Microbiol. 2019;10:1781.", "ArticleIdList": ["PMC6688523", "31428074"]}, {"Citation": "Shehata M.M., Mostafa A., Teubner L., Mahmoud S.H., Kandeil A., Elshesheny R., Frantz R., La Pietra L., Pleschka S., Osman A., Kayali G., Chakraborty T., Ali M.A., Mraheil M.A. Bacterial outer membrane vesicles (OMVs)-based dual vaccine for influenza A H1N1 virus and MERS-CoV. Vaccines (Basel) 2019;7(2)", "ArticleIdList": ["PMC6631769", "31141982"]}, {"Citation": "Schindewolf C., Menachery V.D. Middle East respiratory syndrome vaccine candidates: cautious optimism. Viruses. 2019;11(1)", "ArticleIdList": ["PMC6356267", "30658390"]}, {"Citation": "Song Z., Xu Y., Bao L., Zhang L., Yu P., Qu Y., Zhu H., Zhao W., Han Y., Qin C. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses. 2019;11(1)", "ArticleIdList": ["PMC6357155", "30646565"]}, {"Citation": "Du Z., Zhu F., Guo F., Yang B., Wang T. Detection of antibodies against SARS-CoV-2 in patients with COVID-19. J. Med. Virol. 2020;92:1735\u20131738.", "ArticleIdList": ["PMC7228383", "32243608"]}, {"Citation": "Anderson R.M., Heesterbeek H., Klinkenberg D., Hollingsworth T.D. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet. 2020;395:931\u2013934.", "ArticleIdList": ["PMC7158572", "32164834"]}, {"Citation": "Azkur A.K., et al. Immune response to SARS\u2010CoV\u20102 and mechanisms of immunopathological changes in COVID\u201019. Allergy. 2020;75(7):1564\u20131581.", "ArticleIdList": ["PMC7272948", "32396996"]}, {"Citation": "Le T.T., Andreadakis Z., Kumar A., Rom\u00e1n R.G., Tollefsen S., Saville M., Mayhew S. The COVID-19 vaccine development landscape. Nat. Rev. Drug Discov. 2020;19:305\u2013306.", "ArticleIdList": ["32273591"]}, {"Citation": "DeDiego M.L., \u00c1lvarez E., Almaz\u00e1n F., Rejas M.T., Lamirande E., Roberts A., Shieh W.-J., Zaki S.R., Subbarao K., Enjuanes L. A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo. J. Virol. 2007;81(4):1701\u20131713.", "ArticleIdList": ["PMC1797558", "17108030"]}, {"Citation": "Cao Q., Chen Y.-C., Chen C.-L., Chiu C.-H. SARS-CoV-2 infection in children: transmission dynamics and clinical characteristics. J. Formos. Med. Assoc. 2020;119", "ArticleIdList": ["PMC7126646", "32139299"]}, {"Citation": "Netea M.G., Schlitzer A., Placek K., Joosten L.A.B., Schultze J.L. Innate and adaptive immune memory: an evolutionary continuum in the host's response to pathogens. Cell Host Microbe. 2019;25(1):13\u201326.", "ArticleIdList": ["30629914"]}, {"Citation": "DeZure A., Berkowitz N., Graham B., Ledgerwood J. Whole-inactivated and virus-like particle vaccine strategies for Chikungunya virus. J. Infect. Dis. 2016;214:S497\u2013S499.", "ArticleIdList": ["PMC5137244", "27920180"]}, {"Citation": "Zhou J., Wang W., Zhong Q., Wei H., Yang Z., Yuan X., Zhu R., Tang Z., Wang Y., Xian Q., Tang H., Wen L. Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys. Vaccine. 2005;23:3202\u20133209.", "ArticleIdList": ["PMC7115379", "15837221"]}, {"Citation": "See R., Zakhartchouk A., Petric M., Lawrence D., Mok C., Hogan R., Rowe T., Zitzow L., Karunakaran K., Hitt M., Graham F., Prevec L., Mahony J., Sharon C., Auperin T., Rini J., Tingle A., Scheifele D., Skowronski D., Finlay B. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus. The Journal of general virology. 2006;87:641\u2013650.", "ArticleIdList": ["16476986"]}, {"Citation": "Plante K.S., Rossi S.L., Bergren N.A., Seymour R.L., Weaver S.C. Extended preclinical safety, efficacy and stability testing of a live-attenuated Chikungunya vaccine candidate. PLoS Negl. Trop. Dis. 2015;9(9)", "ArticleIdList": ["PMC4560411", "26340754"]}, {"Citation": "Gao S., Song S., Zhang L. Recent progress in vaccine development against Chikungunya virus. Front. Microbiol. 2019;10:2881.", "ArticleIdList": ["PMC6930866", "31921059"]}, {"Citation": "Ura T., Okuda K., Shimada M. Developments in viral vector-based vaccines. Vaccines (Basel) 2014;2(3):624\u2013641.", "ArticleIdList": ["PMC4494222", "26344749"]}, {"Citation": "Robert-Guroff M. Replicating and non-replicating viral vectors for vaccine development. Curr. Opin. Biotechnol. 2007;18(6):546\u2013556.", "ArticleIdList": ["PMC2245896", "18063357"]}, {"Citation": "Zhao J., Zhao J., Mangalam A.K., Channappanavar R., Fett C., Meyerholz D.K., Agnihothram S., Baric R.S., David C.S., Perlman S. Airway memory CD4(+) T cells mediate protective immunity against emerging respiratory coronaviruses. Immunity. 2016;44(6):1379\u20131391.", "ArticleIdList": ["PMC4917442", "27287409"]}, {"Citation": "Song F., Fux R., Provacia L.B., Volz A., Eickmann M., Becker S., Osterhaus A.D., Haagmans B.L., Sutter G. Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies. J. Virol. 2013;87(21):11950\u201311954.", "ArticleIdList": ["PMC3807317", "23986586"]}, {"Citation": "Enjuanes L., Dediego M.L., Alvarez E., Deming D., Sheahan T., Baric R. Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease. Virus Res. 2008;133(1):45\u201362.", "ArticleIdList": ["PMC2633062", "17416434"]}, {"Citation": "Liu R.Y., Wu L.Z., Huang B.J., Huang J.L., Zhang Y.L., Ke M.L., Wang J.M., Tan W.P., Zhang R.H., Chen H.K., Zeng Y.X., Huang W. Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats. Virus Res. 2005;112(1\u20132):24\u201331.", "ArticleIdList": ["PMC7114075", "16022898"]}, {"Citation": "Prompetchara E., Ketloy C., Palaga T. Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac. J. Allergy Immunol. 2020;38:1\u20139.", "ArticleIdList": ["32105090"]}, {"Citation": "Brito L.A., Kommareddy S., Maione D., Uematsu Y., Giovani C., Berlanda Scorza F., Otten G.R., Yu D., Mandl C.W., Mason P.W., Dormitzer P.R., Ulmer J.B., Geall A.J. In: Advances in Genetics. Huang L., Liu D., Wagner E., editors. Academic Press; 2015. Chapter seven - self-amplifying mRNA vaccines; pp. 179\u2013233.", "ArticleIdList": ["25620012"]}, {"Citation": "Rezaei T., Khalili S., Baradaran B., Mosafer J., Rezaei S., Mokhtarzadeh A., de la Guardia M. Recent advances on HIV DNA vaccines development: stepwise improvements to clinical trials. J. Control. Release. 2019;316:116\u2013137.", "ArticleIdList": ["31669566"]}, {"Citation": "Jahanafrooz Z., Baradaran B., Mosafer J., Hashemzaei M., Rezaei T., Mokhtarzadeh A., Hamblin M.R. Comparison of DNA and mRNA vaccines against cancer. Drug Discov. Today. 2020;25:552\u2013560.", "ArticleIdList": ["PMC7080609", "31843577"]}, {"Citation": "Pardi N., Hogan M., Porter F., Weissman D. mRNA vaccines \u2014 a new era in vaccinology. Nat. Rev. Drug Discov. 2018;17", "ArticleIdList": ["PMC5906799", "29326426"]}, {"Citation": "Gasc\u00f3n A., Pozo-Rodr\u00edguez A., Solin\u00eds M. Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles. Int. J. Nanomedicine. 2014;9:1833\u20131843.", "ArticleIdList": ["PMC3986288", "24748793"]}, {"Citation": "Muthumani K., Falzarano D., Reuschel E., Kraynyak K., Ugen K., Kim P., Maslow J., Kim J.J., Sardesai N.Y., Feldmann H., Weiner D. A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in non-human primates. Int. J. Infect. Dis. 2016;45:23."}, {"Citation": "Wang L., Shi W., Joyce M.G., Modjarrad K., Zhang Y., Leung K., Lees C., Zhou T., Yassine H., Kanekiyo M., Yang Z.-Y., Chen X., Becker M., Freeman M., Vogel L., Johnson J., Olinger G., Todd J., Bagci U., Graham B. Evaluation of candidate vaccine approaches for MERS-CoV. Nat. Commun. 2015;6:7712.", "ArticleIdList": ["PMC4525294", "26218507"]}, {"Citation": "Adnan Shereen M., Khan S., Kazmi A., Bashir N., Siddique R. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J. Adv. Res. 2020;24:91\u201398.", "ArticleIdList": ["PMC7113610", "32257431"]}, {"Citation": "Du L., Tai W., Zhou Y., Jiang S. Vaccines for the prevention against the threat of MERS-CoV. Expert review of vaccines. 2016;15", "ArticleIdList": ["PMC5097835", "26985862"]}, {"Citation": "Wang N., Shang J., Jiang S., Du L. Subunit vaccines against emerging pathogenic human coronaviruses. Front. Microbiol. 2020;11", "ArticleIdList": ["PMC7105881", "32265848"]}, {"Citation": "Bisht H., Roberts A., Vogel L., Subbarao K., Moss B. Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein. Virology. 2005;334(2):160\u2013165.", "ArticleIdList": ["PMC7111832", "15780866"]}, {"Citation": "Subbarao K., McAuliffe J., Vogel L., Fahle G., Fischer S., Tatti K., Packard M., Shieh W.-J., Zaki S., Murphy B. Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J. Virol. 2004;78:3572\u20133577.", "ArticleIdList": ["PMC371090", "15016880"]}, {"Citation": "Bisht H., Roberts A.J., Vogel L., Bukreyev A., Collins P., Murphy B., Subbarao K., Moss B. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc. Natl. Acad. Sci. U. S. A. 2004;101:6641\u20136646.", "ArticleIdList": ["PMC404098", "15096611"]}, {"Citation": "Du L., Jiang S. Middle East respiratory syndrome: current status and future prospects for vaccine development. Expert. Opin. Biol. Ther. 2015;15:1\u20135.", "ArticleIdList": ["PMC4636333", "26414077"]}, {"Citation": "Maslow J.N. Vaccines for emerging infectious diseases: lessons from MERS coronavirus and Zika virus. Hum Vaccin Immunother. 2017;13(12):2918\u20132930.", "ArticleIdList": ["PMC5718785", "28846484"]}, {"Citation": "Du L., Tai W., Yang Y., Zhao G., Zhu Q., Sun S., Liu C., Tao X., Tseng C.-T.K., Perlman S., Jiang S., Zhou Y., Li F. Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines. Nat. Commun. 2016;7(1)", "ArticleIdList": ["PMC5121417", "27874853"]}, {"Citation": "Liu S.J., Leng C.H., Lien S.P., Chi H.Y., Huang C.Y., Lin C.L., Lian W.C., Chen C.J., Hsieh S.L., Chong P. Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates. Vaccine. 2006;24(16):3100\u20133108.", "ArticleIdList": ["PMC7115648", "16494977"]}, {"Citation": "Zheng N., Xia R., Yang C., Yin B., Li Y., Duan C., Liang L., Guo H., Xie Q. Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice. Vaccine. 2009;27(36):5001\u20135007.", "ArticleIdList": ["PMC7115566", "19523911"]}, {"Citation": "He Y., Zhou Y., Siddiqui P., Niu J., Jiang S. Identification of immunodominant epitopes on the membrane protein of the severe acute respiratory syndrome-associated coronavirus. J. Clin. Microbiol. 2005;43(8):3718\u20133726.", "ArticleIdList": ["PMC1234014", "16081901"]}, {"Citation": "Lim Y.X., Ng Y.L., Tam J.P., Liu D.X. Human coronaviruses: a review of virus\u2013host interactions. Diseases. 2016;4(3):26.", "ArticleIdList": ["PMC5456285", "28933406"]}, {"Citation": "Chen I.-Y., Moriyama M., Chang M.-F., Ichinohe T. Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome. Front. Microbiol. 2019;10", "ArticleIdList": ["PMC6361828", "30761102"]}, {"Citation": "Papaioannou N., Beniata O., Vitsos P., Tsitsilonis O., Samara P. Harnessing the immune system to improve cancer therapy. Annals of Translational Medicine. 2016;4", "ArticleIdList": ["PMC4971375", "27563648"]}, {"Citation": "Wong C., Lam K.C., Wu A., Ip W., Lee N., Chan I., Lit L., Hui D., Chan M., Chung S., Sung J. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin. Exp. Immunol. 2004;136:95\u2013103.", "ArticleIdList": ["PMC1808997", "15030519"]}, {"Citation": "Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395", "ArticleIdList": ["PMC7159299", "31986264"]}, {"Citation": "Qin C., Zhou L., Hu Z., Zhang S., Yang S., Tao Y., Xie C., Ma K., Shang K., Wang W., Tian D.-s. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin. Infect. Dis. 2020;71:762\u2013768.", "ArticleIdList": ["PMC7108125", "32161940"]}, {"Citation": "Mair-Jenkins J., Saavedra-Campos M., Baillie K., Cleary P., Khaw F.-M., Lim W.S., Makki S., Rooney K., Nguyen-Van-Tam J., Beck C., Xu X. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J. Infect. Dis. 2014;211", "ArticleIdList": ["PMC4264590", "25030060"]}, {"Citation": "Stockman L., Bellamy R., Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006;3:e343.", "ArticleIdList": ["PMC1564166", "16968120"]}, {"Citation": "Zhao J., Perera R.A.P.M., Kayali G., Meyerholz D., Perlman S., Peiris J.S. Passive immunotherapy with dromedary immune serum in an experimental animal model for MERS coronavirus infection. J. Virol. 2015;89", "ArticleIdList": ["PMC4442417", "25787284"]}, {"Citation": "Shen C., Wang Z., Zhao F., Yang Y., Li J., Yuan J., Wang F., Li D., Yang M., Xing L., Wei J., Xiao H., Yang Y., Qu J., Qing L., Chen L., Xu Z., Peng L., Li Y., Zheng H., Chen F., Huang K., Jiang Y., Liu D., Zhang Z., Liu Y., Liu L. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. Jama. 2020;323:1582\u20131589.", "ArticleIdList": ["PMC7101507", "32219428"]}, {"Citation": "Liu W.J., Zhao M., Liu K., Xu K., Wong G., Tan W., Gao G.F. T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV. Antivir. Res. 2017;137:82\u201392.", "ArticleIdList": ["PMC7113894", "27840203"]}, {"Citation": "Abaturov A.E., Nikulina A.A., Tokareva N.M. vol. 13. 2018. Effect of Treatment With Inosine Pranobex in Acute Respiratory Viral Infections in Children; pp. 490\u2013494."}, {"Citation": "Wang S.-F., Chen K.-H., Chen M., Li W.-Y., Chen Y.-J., Tsao C., Yen M.-y., Huang J., Chen Y.-M. Human-leukocyte antigen class I Cw 1502 and class II DR 0301 genotypes are associated with resistance to severe acute respiratory syndrome (SARS) infection. Viral Immunol. 2011;24:421\u2013426.", "ArticleIdList": ["21958371"]}, {"Citation": "Shanmugaraj B., Siriwattananon K., Wangkanont K., Phoolcharoen W. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for coronavirus disease-19 (COVID-19) Asian Pac. J. Allergy Immunol. 2020;38:10\u201318.", "ArticleIdList": ["32134278"]}, {"Citation": "Nezhad F., Mosaddeghi P., Negahdaripour M., Dehghani Z., Farahmandnejad M., Moghadami M., Nezafat N., Masoompour S.M. 2020. Therapeutic Approaches for COVID-19 Based on the Dynamics of Interferon-mediated Immune Responses."}, {"Citation": "Miyoshi H., Inata Y., Takeuchi M. Distinguishing the effects of inhaled nitric oxide and lung recruitment in pediatric acute respiratory distress syndrome: scope for further improvement. Pediatr. Crit. Care Med. 2018;19:505.", "ArticleIdList": ["29727426"]}, {"Citation": "Fang F. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat. Rev. Microbiol. 2004;2:820\u2013832.", "ArticleIdList": ["15378046"]}, {"Citation": "Darwish I., Miller C., Kain K., Liles W. Inhaled nitric oxide therapy fails to improve outcome in experimental severe influenza. Int. J. Med. Sci. 2012;9:157\u2013162.", "ArticleIdList": ["PMC3258558", "22253563"]}, {"Citation": "Alhazzani W., M\u00f8ller M.H., Arabi Y.M., Loeb M., Gong M.N., Fan E., Oczkowski S., Levy M.M., Derde L., Dzierba A., Du B., Aboodi M., Wunsch H., Cecconi M., Koh Y., Chertow D.S., Maitland K., Alshamsi F., Belley-Cote E., Greco M., Laundy M., Morgan J.S., Kesecioglu J., McGeer A., Mermel L., Mammen M.J., Alexander P.E., Arrington A., Centofanti J.E., Citerio G., Baw B., Memish Z.A., Hammond N., Hayden F.G., Evans L., Rhodes A. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19) Intensive Care Med. 2020:1\u201334.", "ArticleIdList": ["PMC7101866", "32222812"]}, {"Citation": "Totura A.L., Baric R.S. Reply to \"statins may decrease the fatality rate of MERS infection\". mBio. 2015;6(5):e01303\u2013e01315.", "ArticleIdList": ["PMC4611038", "26419878"]}, {"Citation": "DeDiego M.L., Nieto-Torres J.L., Regla-Nava J.A., Jimenez-Guardeno J.M., Fernandez-Delgado R., Fett C., Castano-Rodriguez C., Perlman S., Enjuanes L. Inhibition of NF-kappaB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival. J. Virol. 2014;88(2):913\u2013924.", "ArticleIdList": ["PMC3911641", "24198408"]}, {"Citation": "Xie S., Fan W., He H., Huang F. Role of melatonin in the regulation of pain. J. Pain Res. 2020;13:331\u2013343.", "ArticleIdList": ["PMC7012243", "32104055"]}, {"Citation": "Tao J., Yang M., Wu H., Ma T., He C., Chai M., Zhang X., Zhang J., Ding F., Wang S., Deng S., Zhu K., Song Y., Ji P., Liu H., Lian Z., Liu G. Effects of AANAT overexpression on the inflammatory responses and autophagy activity in the cellular and transgenic animal levels. Autophagy. 2018;14(11):1850\u20131869.", "ArticleIdList": ["PMC6152527", "29985091"]}, {"Citation": "Reiter R., Ma Q., Sharma R. Treatment of ebola and other infectious diseases: melatonin \u201cgoes viral\u201d. Melatonin Research. 2020;3:43\u201357."}, {"Citation": "Zhang R., Wang X., Ni L., Di X., Ma B., Niu S., Liu C., Reiter R. COVID-19: melatonin as a potential adjuvant treatment. Life Sci. 2020:117583.", "ArticleIdList": ["PMC7102583", "32217117"]}, {"Citation": "Simonson O., Mougiakakos D., Heldring N., Bassi G., Johansson H., Dal\u00e9n M., Jitschin R., Rodin S., Corbascio M., Andaloussi S., Wiklander O., Nordin J., Skog J., Romain C., Koestler T., Hellgren-Johansson L., Schiller P., Joachimsson P.-O., H\u00e4gglund H., Blanc K. In vivo effects of mesenchymal stromal cells in two patients with severe acute respiratory distress syndrome. Stem Cells Transl. Med. 2015;4", "ArticleIdList": ["PMC4572899", "26285659"]}, {"Citation": "Sung D.K., Chang Y.S., Sung S.I., Yoo H.S., Ahn S.Y., Park W.S. Antibacterial effect of mesenchymal stem cells against Escherichia coli is mediated by secretion of beta-defensin-2 via toll-like receptor 4 signalling. Cell. Microbiol. 2016;18(3):424\u2013436.", "ArticleIdList": ["PMC5057339", "26350435"]}, {"Citation": "Meisel R., Zibert A., Laryea M., G\u00f6bel U., D\u00e4ubener W., Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2, 3-dioxygenase\u2013mediated tryptophan degradation. Blood. 2004;103(12):4619\u20134621.", "ArticleIdList": ["15001472"]}, {"Citation": "dos Santos C.C., Murthy S., Hu P., Shan Y., Haitsma J.J., Mei S.H., Stewart D.J., Liles W.C. Network analysis of transcriptional responses induced by mesenchymal stem cell treatment of experimental sepsis. Am. J. Pathol. 2012;181(5):1681\u20131692.", "ArticleIdList": ["23083833"]}, {"Citation": "Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., Liu S., Zhao P., Liu H., Zhu L., Tai Y., Bai C., Gao T., Song J.-W., Xia P., Dong J., Zhao J., Wang F.-S. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 2020;8:420\u2013422.", "ArticleIdList": ["PMC7164771", "32085846"]}, {"Citation": "Chan M., Kuok I.T., Leung C., Hui K., Valkenburg S., Lau E., Nicholls J., Fang X., Guan Y., Lee J., Chan R., Webster R., Matthay M., Peiris J.S. Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo. Proc. Natl. Acad. Sci. 2016;113:201601911.", "ArticleIdList": ["PMC4822574", "26976597"]}, {"Citation": "Matthay M., Ware L., Zimmerman G. The acute respiratory distress syndrome. J. Clin. Invest. 2012;122:2731\u20132740.", "ArticleIdList": ["PMC3408735", "22850883"]}, {"Citation": "Silva P., Pelosi P., Rocco P. Personalized pharmacological therapy for ARDS: a light at the end of the tunnel. Expert Opin. Investig. Drugs. 2019;29", "ArticleIdList": ["31778609"]}, {"Citation": "Gu\u00e9rin C., Reignier J., Richard J.-C., Beuret P., Gacouin A., Boulain T., Mercier E., Badet M., Mercat A., Baudin O., Clavel M., Chatellier D., Jaber S., Rosselli S., Mancebo J., Sirodot M., Hilbert G., Bengler C., P. Group Prone positioning in severe acute respiratory distress syndrome. N. Engl. J. Med. 2013;368:2159.", "ArticleIdList": ["23688302"]}, {"Citation": "Curley G., Scott J., Laffey J. Therapeutic potential and mechanisms of action of mesenchymal stromal cells for acute respiratory distress syndrome. Current stem cell research & therapy. 2014;9", "ArticleIdList": ["24588087"]}, {"Citation": "Lee F.-Y., Chen K.-H., Wallace C., Sung P.-H., Sheu J.-J., Chung S.-Y., Chen Y.-L., Lu H.-I., Ko S.-F., Sun C.-K., Chiang H.-J., Chang H.-W., Lee M., Yip H.-K. Xenogeneic human umbilical cord-derived mesenchymal stem cells reduce mortality in rats with acute respiratory distress syndrome complicated by sepsis. Oncotarget. 2017:8.", "ArticleIdList": ["PMC5542214", "28484089"]}, {"Citation": "Wang Y., Hu X. Advance on human umbilical cord mesenchymal stem cells for treatment of ALI in severe burns. Zhonghua wei zhong bing ji jiu yi xue. 2017;29:90\u201396.", "ArticleIdList": ["28459413"]}, {"Citation": "Moodley Y., Atienza D., Manuelpillai U., Samuel C.S., Tchongue J., Ilancheran S., Boyd R., Trounson A. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am. J. Pathol. 2009;175(1):303\u2013313.", "ArticleIdList": ["PMC2708816", "19497992"]}, {"Citation": "Zhu H., Xiong Y., Xia Y., Zhang R., Tian D., Wang T., Dai J., Wang L., Yao H., Jiang H., Yang K., Liu E., Shi Y., Fu Z., Gao L., Zou L. Therapeutic effects of human umbilical cord-derived mesenchymal stem cells in acute lung injury mice. Sci. Rep. 2017;7:39889.", "ArticleIdList": ["PMC5209685", "28051154"]}, {"Citation": "Mills D.R., Mao Q., Chu S., Falcon Girard K., Kraus M., Padbury J.F., De Paepe M.E. Effects of human umbilical cord blood mononuclear cells on respiratory system mechanics in a murine model of neonatal lung injury. Exp. Lung Res. 2017;43(2):66\u201381.", "ArticleIdList": ["28353351"]}, {"Citation": "Xiang B., Chen L., Wang X., Zhao Y., Wang Y., Xiang C. Transplantation of menstrual blood-derived mesenchymal stem cells promotes the repair of LPS-induced acute lung injury. Int. J. Mol. Sci. 2017;18(4)", "ArticleIdList": ["PMC5412275", "28346367"]}, {"Citation": "Antebi B., Mohammadipoor A., Batchinsky A., Cancio L. The promise of mesenchymal stem cell therapy for acute respiratory distress syndrome. J. Trauma Acute Care Surg. 2017;84:1.", "ArticleIdList": ["29019797"]}, {"Citation": "Ong T., McClintock D., Kallet R., Ware L., Matthay M., Liu K. Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients. Crit. Care Med. 2010;38:1845\u20131851.", "ArticleIdList": ["PMC4009623", "20581666"]}, {"Citation": "Sage E., Thakrar R., Janes S. Genetically modified mesenchymal stromal cells in cancer therapy. Cytotherapy. 2016;18:1435\u20131445.", "ArticleIdList": ["PMC5082580", "27745603"]}, {"Citation": "Chen J., Li C., Gao X., Li C., Liang Z., Yu L., Li Y., Xiao X., Chen L. Keratinocyte growth factor gene delivery via mesenchymal stem cells protects against lipopolysaccharide-induced acute lung injury in mice. PLoS One. 2013;8:e83303.", "ArticleIdList": ["PMC3867420", "24367590"]}, {"Citation": "Wyse R., Dunbar G., Rossignol J. Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases. Int. J. Mol. Sci. 2014;15:1719\u20131745.", "ArticleIdList": ["PMC3958818", "24463293"]}, {"Citation": "Xu A., Rodriguez L., Walker K., Mohammadipoor A., Kamucheka R., Cancio L., Batchinsky A., Antebi B. Mesenchymal stem cells reconditioned in their own serum exhibit augmented therapeutic properties in the setting of acute respiratory distress syndrome. Stem Cells Transl. Med. 2019;8", "ArticleIdList": ["PMC6766690", "31219247"]}, {"Citation": "Jerkic M., Masterson C., Ormesher, Gagnon S., Goyal, Rabani, Otulakowski G., Zhang H., Kavanagh, Laffey J. Overexpression of IL-10 enhances the efficacy of human umbilical-cord-derived mesenchymal stromal cells in E. coli pneumosepsis. J. Clin. Med. 2019;8:847.", "ArticleIdList": ["PMC6616885", "31200579"]}, {"Citation": "Wang G., Cao K., Liu K., Xue Y., Roberts A., Li F., Han Y., Rabson A., Wang Y., Shi Y. Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells. Cell Death Differ. 2017;25", "ArticleIdList": ["PMC6030103", "29238069"]}, {"Citation": "Fang X., Abbott J., Cheng L., Colby J., Lee J., Levy B., Matthay M. Human mesenchymal stem (stromal) cells promote the resolution of acute lung injury in part through lipoxin A4. Journal of immunology (Baltimore,Md.: 1950) 2015:195.", "ArticleIdList": ["26116507"]}, {"Citation": "Gupta N., Krasnodembskaya A., Kapetanaki M., Mouded M., Tan X., Serikov V., Matthay M. Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia. Thorax. 2012;67:533\u2013539.", "ArticleIdList": ["PMC3358432", "22250097"]}, {"Citation": "Sung D., Chang Y.S., Sung S., Yoo H., Ahn S.Y., Park W.S. Antibacterial effect of mesenchymal stem cells against Escherichia coli is mediated by secretion of beta-defensin-2 via toll like receptor 4 signaling. Cell. Microbiol. 2015:18.", "ArticleIdList": ["PMC5057339", "26350435"]}, {"Citation": "Mohammadipoor A., Antebi B., Batchinsky A., Cancio L. Therapeutic potential of products derived from mesenchymal stem/stromal cells in pulmonary disease. Respir. Res. 2018;19", "ArticleIdList": ["PMC6234778", "30413158"]}, {"Citation": "Shah T., Predescu D., Predescu S. Mesenchymal stem cells-derived extracellular vesicles in acute respiratory distress syndrome: a review of current literature and potential future treatment options. Clinical and Translational Medicine. 2019;8:25.", "ArticleIdList": ["PMC6739436", "31512000"]}, {"Citation": "Wilson J., Liu K., Zhuo H., Caballero L., McMillan M., Fang X., Cosgrove K., Vojnik R., Calfee C., Lee J.-W., Rogers A., Levitt J., Wiener-Kronish J., Bajwa E., Leavitt A., McKenna D., Taylor B., Matthay M. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir. Med. 2014;3", "ArticleIdList": ["PMC4297579", "25529339"]}, {"Citation": "Lu C.C., Chen M.Y., Chang Y.L. Potential therapeutic agents against COVID-19: what we know so far. J Chin Med Assoc. 2020;83:534\u2013536.", "ArticleIdList": ["PMC7176266", "32243270"]}, {"Citation": "Leng Z., Zhu R., Hou W., Feng Y., Yang Y., Han Q., Shan G., Meng F., Du D., Wang S., Fan J., Wang W., Deng L., Shi H., Li H., Hu Z., Zhang F., Gao J., Liu H., Zhao R. Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging Dis. 2020;11:216\u2013228.", "ArticleIdList": ["PMC7069465", "32257537"]}, {"Citation": "Oroojalian F., Charbgoo F., Hashemi M., Amani A., Yazdian-Robati R., Mokhtarzadeh A., Ramezani M., Hamblin M.R. Recent advances in nanotechnology-based drug delivery systems for the kidney. J. Control. Release. 2020;321:442\u2013462.", "ArticleIdList": ["32067996"]}, {"Citation": "Oroojalian F., Jahanafrooz Z., Chogan F., Rezayan A.H., Malekzade E., Rezaei S.J.T., Nabid M.R., Sahebkar A. Synthesis and evaluation of injectable thermosensitive penta-block copolymer hydrogel (PNIPAAm-PCL-PEG-PCL-PNIPAAm) and star-shaped poly (CL\u2014CO\u2014LA)-b-PEG for wound healing applications. J. Cell. Biochem. 2019;120(10):17194\u201317207.", "ArticleIdList": ["31104319"]}, {"Citation": "Shubhika K. Nanotechnology and medicine - the upside and the downside. International Journal of Drug Development and Research. 2013;5:1\u201310."}, {"Citation": "Rizvi S., Saleh A. Applications of nanoparticle systems in drug delivery technology. Saudi Pharmaceutical Journal. 2018;26:64\u201370.", "ArticleIdList": ["PMC5783816", "29379334"]}, {"Citation": "Lu X., Zhu T., Chen C., Liu Y. Right or left: the role of nanoparticles in pulmonary diseases. Int. J. Mol. Sci. 2014;15:17577\u201317600.", "ArticleIdList": ["PMC4227179", "25268624"]}, {"Citation": "van Rijt S., Bein T., Meiners S. Medical nanoparticles for next generation drug delivery to the lungs. Eur. Respir. J. 2014;44", "ArticleIdList": ["24791828"]}, {"Citation": "Pati R., Shevtsov M., Sonawane A. Nanoparticle vaccines against infectious diseases. Front. Immunol. 2018;9(2224)", "ArticleIdList": ["PMC6180194", "30337923"]}, {"Citation": "Soltani F., Parhiz H., Mokhtarzadeh A., Ramezani M. Synthetic and biological vesicular nano-carriers designed for gene delivery. Curr. Pharm. Des. 2015;21(42):6214\u20136235.", "ArticleIdList": ["26503143"]}, {"Citation": "Afsharzadeh M., Hashemi M., Mokhtarzadeh A., Abnous K., Ramezani M. Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment. Artificial Cells, Nanomedicine and Biotechnology. 2018;46(6):1095\u20131110.", "ArticleIdList": ["28954547"]}, {"Citation": "Jackman J., Lee J., Cho N. Nanomedicine for infectious disease applications: innovation towards broad-spectrum treatment of viral infections. Small (Weinheim an der Bergstrasse, Germany) 2015:12.", "ArticleIdList": ["26551316"]}, {"Citation": "Coleman C., Liu Y., Mu H., Taylor J., Massare M., Flyer D., Smith G., Frieman M. Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice. Vaccine. 2014;32", "ArticleIdList": ["PMC4058772", "24736006"]}, {"Citation": "Coleman C., Venkataraman T., Liu Y., Glenn G., Smith G., Flyer D., Frieman M. MERS-CoV spike nanoparticles protect mice from MERS-CoV infection. Vaccine. 2017;35", "ArticleIdList": ["PMC5423355", "28237499"]}, {"Citation": "Jung S.-Y., Kang K., Lee E.-Y., Seo D.-W., Kim H.-L., Kim H., Kwon T., Park H.-L., Kim H., Lee S.-M., Nam J.-H. Heterologous prime\u2013boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus. Vaccine. 2018;36", "ArticleIdList": ["PMC7115429", "29739720"]}, {"Citation": "Roh C. A facile inhibitor screening of SARS coronavirus N protein using nanoparticle-based RNA oligonucleotide. Int. J. Nanomedicine. 2012;7:2173\u20132179.", "ArticleIdList": ["PMC3356205", "22619553"]}, {"Citation": "Mokhtarzadeh A., Eivazzadeh-Keihan R., Pashazadeh P., Hejazi M., Gharaatifar N., Hasanzadeh M., Baradaran B., de la Guardia M. Nanomaterial-based biosensors for detection of pathogenic virus. TrAC Trends Anal. Chem. 2017;97:445\u2013457.", "ArticleIdList": ["PMC7126209", "32287543"]}, {"Citation": "Hasanzadeh M., Tagi S., Solhi E., Mokhtarzadeh A., Shadjou N., Eftekhari A., Mahboob S. An innovative immunosensor for ultrasensitive detection of breast cancer specific carbohydrate (CA 15-3) in unprocessed human plasma and MCF-7 breast cancer cell lysates using gold nanospear electrochemically assembled onto thiolated graphene quantum dots. Int. J. Biol. Macromol. 2018;114:1008\u20131017.", "ArticleIdList": ["29621501"]}, {"Citation": "Hassanpour S., Baradaran B., Hejazi M., Hasanzadeh M., Mokhtarzadeh A., de la Guardia M. Recent trends in rapid detection of influenza infections by bio and nanobiosensor. TrAC Trends Anal. Chem. 2018;98:201\u2013215."}, {"Citation": "Hasanzadeh M., Karimzadeh A., Sadeghi S., Mokhtarzadeh A., Shadjou N., Jouyban A. Graphene quantum dot as an electrically conductive material toward low potential detection: a new platform for interface science. J. Mater. Sci. Mater. Electron. 2016;27(6):6488\u20136495."}, {"Citation": "Ishikawa F., Chang H.-K., Curreli M., Liao H.-I., Olson C., Chen P.-C., Zhang R., Roberts R., Sun R., Cote R., Thompson M., Zhou C. Label-free, electrical detection of the SARS virus N-protein with nanowire biosensors utilizing antibody mimics as capture probes. ACS Nano. 2009;3:1219\u20131224.", "ArticleIdList": ["PMC2765574", "19422193"]}, {"Citation": "Teengam P., Tuantranont A., Vilaivan T., Chailapakul O., Henry C. Multiplex paper-based colorimetric DNA sensor using pyrrolidinyl peptide nucleic acid-induced AgNPs aggregation for detecting MERS-CoV, MTB, and HPV oligonucleotides. Anal. Chem. 2017;89", "ArticleIdList": ["PMC7077925", "28394582"]}, {"Citation": "Kim H., Park M., Hwang J., Kim J., Chung D.-R., Lee K.-S., Kang M. Development of label-free colorimetric assay for MERS-CoV using gold nanoparticles. ACS Sensors. 2019;4", "ArticleIdList": ["31062580"]}, {"Citation": "Pimentel T.A., Yan Z., Jeffers S.A., Holmes K.V., Hodges R.S., Burkhard P. Peptide nanoparticles as novel immunogens: design and analysis of a prototypic severe acute respiratory syndrome vaccine. Chem. Biol. Drug Des. 2009;73(1):53\u201361.", "ArticleIdList": ["PMC2756483", "19152635"]}, {"Citation": "Zhang J., Zeng H., Gu J., Li H., Zheng L., Zou Q. Progress and prospects on vaccine development against SARS-CoV-2. Vaccines (Basel) 2020;8(2)", "ArticleIdList": ["PMC7349596", "32235387"]}, {"Citation": "Liu C., Zhou Q., Li Y., Garner L.V., Watkins S.P., Carter L.J., Smoot J., Gregg A.C., Daniels A.D., Jervey S., Albaiu D. Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases. ACS Cent Sci. 2020;6(3):315\u2013331.", "ArticleIdList": ["PMC10467574", "32226821"]}, {"Citation": "Kim J.Y., Choe P.G., Oh Y., Oh K.J., Kim J., Park S.J., Park J.H., Na H.K., Oh M.D. The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures. J. Korean Med. Sci. 2020;35(5):e61.", "ArticleIdList": ["PMC7008073", "32030925"]}]}], "History": [{"Year": "2020", "Month": "8", "Day": "19"}, {"Year": "2020", "Month": "9", "Day": "15"}, {"Year": "2020", "Month": "9", "Day": "22"}, {"Year": "2020", "Month": "9", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "12", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "29", "Hour": "20", "Minute": "8"}, {"Year": "2020", "Month": "9", "Day": "28"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32991900", "PMC7521454", "10.1016/j.ijbiomac.2020.09.204", "S0141-8130(20)34564-5"]}}]}